Supplementary Data from Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein ß (2023)
Attributed to:
A Combined and Automated High Throughput Parallel Peptide Synthesis Platform.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.22523440
Publication URI: http://dx.doi.org/10.1158/1535-7163.22523440
Type: Other